Holen Sie sich die Stockscreener-App
1.05
2.94%
0.03
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt XAIR?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.02
Offen:
$1.05
24-Stunden-Volumen:
569.40K
Relative Volume:
0.08
Marktkapitalisierung:
$11.06M
Einnahmen:
$1.78M
Nettoeinkommen (Verlust:
$-58.35M
KGV:
-0.6402
EPS:
-1.64
Netto-Cashflow:
$-56.66M
1W Leistung:
-8.70%
1M Leistung:
-52.05%
6M Leistung:
-57.14%
1J Leistung:
+182.71%
1-Tages-Spanne:
$1.00
$1.15
1-Wochen-Bereich:
$0.9515
$1.25
52-Wochen-Spanne:
$0.1521
$4.78
Beyond Air Inc Stock (XAIR) Company Profile
Firmenname
Beyond Air Inc
Sektor
Branche
Telefon
516-665-8200
Adresse
900 STEWART AVENUE, GARDEN CITY, NY
Compare XAIR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XAIR
Beyond Air Inc
|
1.05 | 10.74M | 1.78M | -58.35M | -56.66M | -1.64 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-17 | Eingeleitet | D. Boral Capital | Buy |
| 2024-06-25 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-07-28 | Eingeleitet | Piper Sandler | Overweight |
| 2023-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-04-28 | Eingeleitet | Truist | Buy |
| 2019-10-22 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Beyond Air Inc Aktie (XAIR) Neueste Nachrichten
XAIR Maintains Revenue Outlook for Fiscal Year Ending 2026 - GuruFocus
Beyond Air (XAIR) Reports Strong Q3 Revenue With Promising Growt - GuruFocus
Beyond Air Shares Rise Intraday After Q3 FY2026 Revenue More Than Doubles; Loss Narrows on Cost Cuts - AlphaStreet News
Beyond Air Reports Strong Q3 Growth and Funding Extension - TipRanks
Beyond Air, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Beyond Air, Inc. SEC 10-Q Report - TradingView
XAIR: Quarterly revenue doubled and net loss narrowed, but additional funding is needed within a year - TradingView
Earnings call transcript: Beyond Air Q3 2026 sees revenue growth and cost cuts - Investing.com India
XAIR: Revenue up 105% year-over-year, with strong cost controls and global LungFit PH expansion - TradingView
Beyond Air Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update - marketscreener.com
BEYOND AIR INC (NASDAQ:XAIR) Posts Revenue Beat, Reaffirms Guidance in Q3 2026 - ChartMill
Beyond Air XAIR Q3 2026 Earnings Call Transcript - The Globe and Mail
Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
How Beyond Air Inc. stock compares to market leadersJuly 2025 Gainers & Long Hold Capital Preservation Plans - mfd.ru
Beyond Air Earnings Preview - Benzinga
BEYOND AIR Q3 2026 Earnings Preview: Recent $XAIR Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Geopolitics Watch: Can Beyond Air Inc outperform under higher oil pricesWeekly Gains Summary & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Why Beyond Air Inc. stock is seen as undervaluedLayoff News & Precise Swing Trade Entry Alerts - mfd.ru
Will Beyond Air Inc benefit from geopolitical trendsEarnings Summary Report & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Big Money Moves: Is Beyond Air Inc showing insider buyingJuly 2025 Patterns & Reliable Intraday Trade Alerts - baoquankhu1.vn
Beyond Cancer to present Phase 1 UNO trial data at AACR meeting - Investing.com Australia
Beyond Cancer Abstract Featuring Phase 1 Data on Intratumoral Ultra-High Concentration Nitric Oxide (UNO) in Solid Tumor Metastases to be Presented at the AACR Annual Meeting 2026 - The Manila Times
Ultra-high nitric oxide cancer immunotherapy data heads to AACR 2026 - stocktitan.net
Published on: 2026-02-04 19:27:54 - baoquankhu1.vn
Beyond Air Stockholders Approve Directors and Equity Plan - TipRanks
Portfolio Recap: Will Beyond Air Inc outperform the market in YEARJuly 2025 News Drivers & Weekly High Return Opportunities - baoquankhu1.vn
Can Beyond Air Inc outperform under higher oil pricesMarket Performance Recap & Expert Approved Trade Ideas - baoquankhu1.vn
Beyond Air (XAIR) Announces Sale of 7.86 Million Shares of Commo - GuruFocus
XTL Biopharmaceuticals Aims to Acquire Stake in NeuroNOS from Be - GuruFocus
XTL Update on Recent Developments - The Manila Times
Is Beyond Air Inc. stock good for income investorsPortfolio Gains Summary & AI Based Trade Execution Alerts - mfd.ru
Is Beyond Air Inc. stock a buy or sell2025 Top Decliners & Long-Term Growth Plans - mfd.ru
Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences - The Manila Times
Beyond Air CEO lines up two investor conference appearances - Stock Titan
Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and Webcast - The Manila Times
Beyond Air, Inc. to Report Q3 Fiscal 2025 Financial Results on February 13, 2026 - Quiver Quantitative
Merger Talk: Will Beyond Air Inc stock benefit from M ADip Buying & High Accuracy Investment Signals - baoquankhu1.vn
Beyond Air Announces $5 Million Private Placement Financing - TipRanks
Short Squeeze: Will Beyond Air Inc stock benefit from M AMarket Trend Report & Daily Volume Surge Signals - baoquankhu1.vn
Can Beyond Air Inc continue delivering strong returnsJuly 2025 Technicals & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Beyond Air (XAIR) Analyst Rating Maintained as Buy at $11.00 by D. Boral Capital | XAIR Stock News - GuruFocus
Exit Recap: Is Beyond Air Inc showing insider buyingTrade Entry Report & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Beyond Air Signs Multiple Material Agreements - TradingView
Published on: 2026-01-20 07:10:21 - baoquankhu1.vn
CEO Change: Does Beyond Air Inc have a competitive edgeQuarterly Market Summary & Verified Momentum Stock Watchlist - baoquankhu1.vn
Beyond Air, Inc. (NASDAQ:XAIR) Short Interest Update - Defense World
Analyst Downgrade: Is Beyond Air Inc stock a buy or sellJuly 2025 Technicals & Free Community Supported Trade Ideas - baoquankhu1.vn
XAIR: Second-generation nitric oxide device and global expansion set to accelerate growth - TradingView — Track All Markets
Market Review: Does Trump Media Technology Group Corp Equity Warrant have a sustainable dividend2025 Price Momentum & Weekly High Conviction Ideas - baoquankhu1.vn
Beyond Air’s Nitric Oxide Bet Faces Cash Burn And Dilution - Finimize
NY-based Beyond Air announces USD 5M private placement - Medical Buyer
Finanzdaten der Beyond Air Inc-Aktie (XAIR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.33%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):